# In-Q-Tel

Type: vc_firm

Source: GetYourBrief — https://getyourbrief.com/entity/in-q-tel-vcfirm
Canonical HTML page: https://getyourbrief.com/entity/in-q-tel-vcfirm

## Recent coverage (4 stories, network-wide)

### Twenty’s $100M Series B makes it first cyber warfare unicorn at $1B
2026-06-18 00:48:22 · Sector: startups · Sentiment: Positive · Impact: 8/10 · Sources: 2

Twenty becomes the first venture-backed offensive cyber warfare unicorn after a $100 million Series B led by Accel, raising $138 million total since 2024 and validating a new startup category built on government offense contracts.
Full story: https://getstartupbrief.com/story/twenty-startup-funding-100m-1b-valuation

### Twenty’s $1B cyber warfare unicorn: AI offense reshapes defense tech landscape
2026-06-18 00:48:11 · Sector: space · Sentiment: Positive · Impact: 8/10 · Sources: 2

The $1 billion valuation of offensive cyber startup Twenty signals a paradigm shift in defense tech procurement, with AI-driven attack capabilities becoming a critical asset for protecting space and other military domains.
Full story: https://getspacebrief.com/story/twenty-cyber-warfare-1b-space-defense

### Twenty’s $100M raise creates first offensive cyber unicorn at $1B
2026-06-18 00:47:58 · Sector: cyber · Sentiment: Positive · Impact: 8/10 · Sources: 2

Cybersecurity professionals must now reckon with the commercial industrialization of offensive AI cyber weapons, as Twenty achieves a $1 billion valuation with fresh funding to expand its attack capabilities for government clients.
Full story: https://getcyberbrief.com/story/twenty-offensive-cyber-1b-funding

### Colossal Biosciences Faces Ethical Backlash Over $225M Mammoth Revival Project
2026-03-04 21:16:38 · Sector: startups · Sentiment: Neutral · Impact: 7/10 · Sources: 4

Colossal Biosciences is advancing its mission to revive the woolly mammoth by 2028, sparking intense debate over the ethics of de-extinction. While the startup has secured over $225 million in venture capital, critics argue the project is a costly distraction from urgent conservation efforts for living species.
Full story: https://getstartupbrief.com/story/colossal-biosciences-mammoth-revival-controversy

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.